Toll-like receptors: lessons to learn from normal and malignant human B cells - Archive ouverte HAL Access content directly
Journal Articles Blood Year : 2008

Toll-like receptors: lessons to learn from normal and malignant human B cells

Abstract

The humoral immune system senses microbes via recognition of specific microbial molecular motifs by Toll-like receptors (TLRs). These encounters promote plasma cell differentiation and antibody production. Recent studies have demonstrated the importance of the TLR system in enhancing antibody-mediated defense against infections and maintaining memory B cells. These results have led the way to the design of vaccines that target B cells by engaging TLRs. In hematologic malignancies, cells often retain B cell-specific receptors and associated functions. Among these, TLRs are currently exploited to target different subclasses of B-cell leukemia, and TLR agonists are currently being evaluated in clinical trials. However, accumulating evidence suggests that endogenous TLR ligands or chronic infections promote tumor growth, thus providing a need for further investigations to decipher the exact function of TLRs in the B-cell lineage and in neoplastic B cells. The aim of this review is to present and discuss the latest advances with regard to the expression and function of TLRs in both healthy and malignant B cells. Special attention will be focused on the growth-promoting effects of TLR ligands on leukemic B cells and their potential clinical impact.

Dates and versions

inserm-02459027 , version 1 (29-01-2020)

Identifiers

Cite

David Chiron, Isabelle Bekeredjian-Ding, Catherine Pellat-Deceunynck, Régis Bataille, Gaetan Jego. Toll-like receptors: lessons to learn from normal and malignant human B cells. Blood, 2008, ⟨10.1182/blood-2008-02-140673⟩. ⟨inserm-02459027⟩
29 View
1 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More